Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2024 | The future of CAR T-reg cells: organ transplantation & autoimmune disease

Zinaida Good • 9 Apr 2024
AACR 2024
General Non-Malignant

In this video, Zinaida Good, PhD, Stanford University, Stanford, CA, briefly discusses some settings in which CAR-T regulatory (CAR T-reg) cells hold therapeutic potential, such as organ transplantation and autoimmune disease. Dr Good highlights the necessity of developing protocols that will ensure the purity and stability of CAR T-regs. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Zinaida Good

2:09
Using lineage tracing to define responding CAR T-cells in patients with LBCL
Zinaida Good • 9 Apr 2024
1:47
Lineage tracing of CAR-T cells in patients with B-cell malignancies & the value of this approach
Zinaida Good • 16 Apr 2023
1:29
Evaluating post-infusion CAR-Treg cells to identify patients resistant to CD19 CAR-T therapy
Zinaida Good • 16 Apr 2023
2:06
Improving our understanding of CAR-T therapy to avoid T-cell exhaustion
Zinaida Good • 12 Apr 2022

Related Videos

3:12
Addressing cardiotoxicity following CAR-T therapy and improving clinical practice
Arjun Ghosh • 25 Apr 2024
4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals